SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy

por Nguyen, Huy, Chen, Hui, Vuppalapaty, Meghah, Whisler, Elizabeth, Logas, Kelsey Ronarda, Sampathkumar, Parthasarathy, Fletcher, Russell Byron, Sura, Asmiti, Suen, Nicholas, Gupta, Suhani, Lopez, Tom, Ye, Jay, Tu, Shengjiang, Bolaki, Menaka, Yeh, Wen-Chen, Li, Yang, Lee, Sung-Jin
Publicado 2022

Therapeutic blood-brain barrier modulation and stroke treatment by a bioengineered FZD(4)-selective WNT surrogate in mice

por Ding, Jie, Lee, Sung-Jin, Vlahos, Lukas, Yuki, Kanako, Rada, Cara C., van Unen, Vincent, Vuppalapaty, Meghah, Chen, Hui, Sura, Asmiti, McCormick, Aaron K., Tomaske, Madeline, Alwahabi, Samira, Nguyen, Huy, Nowatzke, William, Kim, Lily, Kelly, Lisa, Vollrath, Douglas, Califano, Andrea, Yeh, Wen-Chen, Li, Yang, Kuo, Calvin J.
Publicado 2023

Robust Colonic Epithelial Regeneration and Amelioration of Colitis via FZD-Specific Activation of Wnt Signaling

por Xie, Liqin, Fletcher, Russell B., Bhatia, Diksha, Shah, Darshini, Phipps, Jacqueline, Deshmukh, Shalaka, Zhang, Haili, Ye, Jingjing, Lee, Sungjin, Le, Lucas, Newman, Maureen, Chen, Hui, Sura, Asmiti, Gupta, Suhani, Sanman, Laura E., Yang, Fan, Meng, Weixu, Baribault, Helene, Vanhove, Geertrui F., Yeh, Wen-Chen, Li, Yang, Lu, Chenggang
Publicado 2022